GTP hydrolysis is modulated by Arg34 in the RASopathy-associated KRASP34R
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
GTP hydrolysis is modulated by Arg34 in the RASopathy-associated KRASP34R
Authors
Keywords
-
Journal
Birth Defects Research
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2020-03-19
DOI
10.1002/bdr2.1647
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tissue-Specific Oncogenic Activity of KRASA146T
- (2019) Emily J. Poulin et al. Cancer Discovery
- Structural basis of the atypical activation mechanism of KRAS V14I
- (2019) Asim K. Bera et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunity
- (2019) Jude Canon et al. NATURE
- Atypical KRASG12R Mutant Is Impaired in PI3K Signaling and Macropinocytosis in Pancreatic Cancer
- (2019) G. Aaron Hobbs et al. Cancer Discovery
- Targeting KRAS Mutant Cancers with a Covalent G12C-Specific Inhibitor
- (2018) Matthew R. Janes et al. CELL
- Quantitative Measurement of Intrinsic GTP Hydrolysis for Carcinogenic Glutamine 61 Mutants in H-Ras
- (2018) Elisa T. Novelli et al. BIOCHEMISTRY
- Discovery of Tetrahydropyridopyrimidines as Irreversible Covalent Inhibitors of KRAS-G12C with In Vivo Activity
- (2018) Jay B. Fell et al. ACS Medicinal Chemistry Letters
- Rationale for RAS mutation-tailored therapies
- (2017) Steven K Montalvo et al. Future Oncology
- MolProbity: More and better reference data for improved all-atom structure validation
- (2017) Christopher J. Williams et al. PROTEIN SCIENCE
- Mechanism of the intrinsic arginine finger in heterotrimeric G proteins
- (2016) Daniel Mann et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Differential Reprogramming of Isogenic Colorectal Cancer Cells by Distinct Activating KRAS Mutations
- (2015) Dean E. Hammond et al. JOURNAL OF PROTEOME RESEARCH
- Biochemical and Structural Analysis of Common Cancer-Associated KRAS Mutations
- (2015) J. C. Hunter et al. MOLECULAR CANCER RESEARCH
- K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions
- (2013) Jonathan M. Ostrem et al. NATURE
- NMR-based functional profiling of RASopathies and oncogenic RAS mutations
- (2013) M. J. Smith et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Overview of theCCP4 suite and current developments
- (2011) Martyn D. Winn et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Noonan syndrome and clinically related disorders
- (2011) Marco Tartaglia et al. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM
- Features and development ofCoot
- (2010) P. Emsley et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- PHENIX: a comprehensive Python-based system for macromolecular structure solution
- (2010) Paul D. Adams et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Germline KRAS mutations cause aberrant biochemical and physical properties leading to developmental disorders
- (2010) Lothar Gremer et al. HUMAN MUTATION
- Noonan Syndrome: Clinical Features, Diagnosis, and Management Guidelines
- (2010) A. A. Romano et al. PEDIATRICS
- Allosteric modulation of Ras positions Q61 for a direct role in catalysis
- (2010) G. Buhrman et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The RASopathies: developmental syndromes of Ras/MAPK pathway dysregulation
- (2009) William E Tidyman et al. CURRENT OPINION IN GENETICS & DEVELOPMENT
- Noonan, Costello and cardio–facio–cutaneous syndromes: dysregulation of the Ras–MAPK pathway
- (2008) William E. Tidyman et al. EXPERT REVIEWS IN MOLECULAR MEDICINE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started